Saint-Mandé, France

Karim Fizazi

This inventor holds 1 USPTO granted patent. Top assignee: Institut Gustave Roussy. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karim Fizazi. Retrieved from https://idiyas.com/inventor/karim-fizazi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Karim Fizazi: Innovator in Prostate Cancer Research

Introduction

Karim Fizazi is a prominent inventor based in Saint-Mandé, France. He has made significant contributions to the field of cancer research, particularly in the area of prostate cancer. His innovative work has led to the development of valuable tools for screening and understanding this disease.

Latest Patents

Karim Fizazi holds a patent titled "Prostate cancer cell lines and their use in screening method." This invention relates to a prostate cancer cell line with CNCM deposit number I-4126. The patent outlines the use of this cell line for preparing resistant prostate cancer cell lines, as well as the application of these cell lines for screening compounds of interest. He has 1 patent to his name, showcasing his commitment to advancing cancer research.

Career Highlights

Fizazi is affiliated with the Institut Gustave Roussy, a leading cancer research institution. His work at this prestigious organization has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in oncology.

Collaborations

Throughout his career, Karim Fizazi has worked alongside notable colleagues, including Catherine Gaudin and Jean Benard. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

Karim Fizazi's contributions to prostate cancer research through his innovative patent and collaborations highlight his dedication to improving cancer treatment and screening methods. His work continues to inspire advancements in the field of oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…